Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Raises €12.5 Million to Advance NCX 470 into Phase 3 in Glaucoma

November 18, 2019

View Press Release Corporate presentation Contact us
Previous